این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Pediatric Hematology and Oncology، جلد ۱، شماره ۱، صفحات ۱۴-۱۸
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Sequential Deferoxamine - Deferasirox in Treatment of Major Thalassemia with Iron Overload
چکیده انگلیسی مقاله Abstract Background Iron overload is a major problem in patients with major thalassemia. An effective and safe iron chelator protocol with high compliance rate plays an important role in treatment of these patients. This study was done to assess the efficacy and safety of the sequential deferoxamine and deferasirox protocol in major thalassemia patients in Khuzestan province, Iran. Material and Method Sixty two patients were studied aged between 2 to 30 years old. A regimen consisted of 4 days deferasirox followed by 3 days deferoxamine. The duration of trial was 6 months. The efficacy was determined by comparison of ferritin level before and after treatment. Results Serum ferritin changed from 3590 ng/ml to 2563 ng /ml, which decreased significantly. During study 21% of patients experienced at least one side effect. Conclusion This is a new regimen with high efficacy, low toxicity and acceptable compliance.
کلیدواژه‌های انگلیسی مقاله Sequential, Deferoxamine, Deferasirox, Major thalassemia.
نویسندگان مقاله بیژن کیخایی | bijan keikhaei
department of pediatrics, research center for thalassemia hemoglobinopathy, joundishapur university of medical science
نشانی اینترنتی http://ijpho.ssu.ac.ir/browse.php?a_code=A-10-1-4&slc_lang=en&sid=en
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده 1
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات